 Bronchodilator Agents
"Bronchodilator Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that cause an increase in the expansion of a bronchus or bronchial tubes.
| Descriptor ID |
D001993
|
| MeSH Number(s) |
D27.505.696.663.050.110 D27.505.954.796.050.100
|
| Concept/Terms |
Bronchodilator Agents- Bronchodilator Agents
- Agents, Bronchodilator
- Bronchial-Dilating Agents
- Agents, Bronchial-Dilating
- Bronchial Dilating Agents
- Bronchodilators
Broncholytic Effect- Broncholytic Effect
- Effect, Broncholytic
- Broncholytic Effects
- Effects, Broncholytic
Bronchodilator Effect- Bronchodilator Effect
- Effect, Bronchodilator
- Bronchodilator Effects
- Effects, Bronchodilator
|
Below are MeSH descriptors whose meaning is more general than "Bronchodilator Agents".
Below are MeSH descriptors whose meaning is more specific than "Bronchodilator Agents".
This graph shows the total number of publications written about "Bronchodilator Agents" by people in UAMS Profiles by year, and whether "Bronchodilator Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 1 | 1 | 2 | | 2021 | 1 | 0 | 1 | | 2020 | 2 | 1 | 3 | | 2019 | 1 | 1 | 2 | | 2018 | 2 | 1 | 3 | | 2017 | 3 | 1 | 4 | | 2016 | 1 | 2 | 3 | | 2015 | 5 | 0 | 5 | | 2014 | 1 | 0 | 1 | | 2013 | 4 | 2 | 6 | | 2012 | 2 | 0 | 2 | | 2011 | 2 | 0 | 2 | | 2010 | 5 | 0 | 5 | | 2009 | 0 | 1 | 1 | | 2008 | 0 | 2 | 2 | | 2007 | 2 | 2 | 4 | | 2006 | 0 | 3 | 3 | | 2005 | 1 | 0 | 1 | | 2004 | 0 | 1 | 1 | | 2002 | 0 | 2 | 2 | | 1998 | 1 | 0 | 1 | | 1997 | 3 | 0 | 3 | | 1996 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Bronchodilator Agents" by people in Profiles over the past ten years.
-
Berlinski A. Changing Positions When New Data Are Available Is Essential to Science: A Tale of a Breath-Enhanced Nebulizer. Respir Care. 2022 08; 67(8):1064-1065.
-
Cox C, Patel K, Cantu R, Akmyradov C, Irby K. Hypokalemia Measurement and Management in Patients With Status Asthmaticus on Continuous Albuterol. Hosp Pediatr. 2022 02 01; 12(2):198-204.
-
Qaqish R, Berlinski A. Effects of Shake-Actuation Delay on Delivered Dose and Aerosol Characteristics of an Albuterol Suspension From a Pressurized Metered-Dose Inhaler. Respir Care. 2021 Aug; 66(8):1315-1322.
-
Bagwell T, Hollingsworth A, Thompson T, Abramo T, Huckabee M, Chang D, Crawley L, Robbins JM. Management of Croup in the Emergency Department: The Role of Multidose Nebulized Epinephrine. Pediatr Emerg Care. 2020 Jul; 36(7):e387-e392.
-
Berlinski A. 2019 Year in Review: Aerosol Therapy. Respir Care. 2020 May; 65(5):705-712.
-
Pertzborn MC, Prabhakaran S, Abu-Hasan M, Baker D, Wu S, Wu Y, Hendeles L. Continuous Albuterol With Benzalkonium in Children Hospitalized With Severe Asthma. Pediatrics. 2020 04; 145(4).
-
Berlinski A, Velasco J. Albuterol Delivery Efficiency in a Pediatric Model of Noninvasive Ventilation With a Single-Limb Circuit. Respir Care. 2019 Nov; 64(11):1366-1370.
-
Kennedy JL, Kurten RC, McCullough S, Panettieri RA, Koziol-White C, Jones SM, Caid K, Gill PS, Roberts D, Jaeschke H, McGill MR, James L. Acetaminophen is both bronchodilatory and bronchoprotective in human precision cut lung slice airways. Xenobiotica. 2019 Sep; 49(9):1106-1115.
-
Gallagher JL, Rivera RD, Van Shepard K, Roushan T, Ahsan G, Ahamed SI, Chiu A, Jurken M, Simpson PM, Nugent M, Gobin KS, Wen CKF, Eldredge CE. Life-Threatening Allergies: Using a Patient-Engaged Approach. Telemed J E Health. 2019 04; 25(4):319-325.
-
Deas SD, Huprikar N. Dual bronchodilator therapy for chronic obstructive pulmonary disease: evidence for the efficacy and Safety of fixed dose combination treatments in the setting of recent guideline updates. Curr Opin Pulm Med. 2018 03; 24(2):130-137.
-
Awad SM, Berlinski A. Crossover Evaluation of Compressors and Nebulizers Typically Used by Cystic Fibrosis Patients. Respir Care. 2018 Mar; 63(3):294-300.
-
Berlinski A, von Hollen D, Pritchard JN, Hatley RH. Delay Between Shaking and Actuation of a Hydrofluoroalkane Fluticasone Pressurized Metered-Dose Inhaler. Respir Care. 2018 Mar; 63(3):289-293.
-
Velasco J, Berlinski A. Albuterol Delivery Efficiency in a Pediatric Model of Noninvasive Ventilation With Double-Limb Circuit. Respir Care. 2018 Feb; 63(2):141-146.
-
Berlinski A, Pennington D. Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics. Respir Care. 2017 Sep; 62(9):1123-1130.
-
Helm ME. Value-Based Insurance Design Pharmacy Benefits for Children and Youth With Special Health Care Needs: Principles and Opportunities. Pediatrics. 2017 May; 139(Suppl 2):S117-S126.
-
Berlinski A, von Hollen D, Hatley RHM, Hardaker LEA, Nikander K. Drug Delivery in Asthmatic Children Following Coordinated and Uncoordinated Inhalation Maneuvers: A Randomized Crossover Trial. J Aerosol Med Pulm Drug Deliv. 2017 Jun; 30(3):182-189.
-
Cockerham JR, Lowe GR, Willis R, Stecks RM, Berlinski A. Quality Improvement Project to Improve Timeliness Between Bronchodilator Treatments from Emergency Department to Medical Wards. Respir Care. 2016 Dec; 61(12):1573-1579.
-
Berlinski A, Cooper B. Oronasal and Tracheostomy Delivery of Soft Mist and Pressurized Metered-Dose Inhalers With Valved Holding Chamber. Respir Care. 2016 Jul; 61(7):913-9.
-
Berlinski A. Transnasal Aerosol Delivery to Pediatric Patients: Jet Versus Vibrating Mesh--Reply. Respir Care. 2015 Oct; 60(10):e168-9.
-
Cooper B, Berlinski A. Albuterol Delivery via Facial and Tracheostomy Route in a Model of a Spontaneously Breathing Child. Respir Care. 2015 Dec; 60(12):1749-58.
-
Berlinski A, Willis JR. Effect of Tidal Volume and Nebulizer Type and Position on Albuterol Delivery in a Pediatric Model of Mechanical Ventilation. Respir Care. 2015 Oct; 60(10):1424-30.
-
Todd Tzanetos DR, Housley JJ, Barr FE, May WL, Landers CD. Implementation of an inhaled nitric oxide protocol decreases direct cost associated with its use. Respir Care. 2015 May; 60(5):644-50.
-
El Taoum KK, Xi J, Kim J, Berlinski A. In Vitro Evaluation of Aerosols Delivered via the Nasal Route. Respir Care. 2015 Jul; 60(7):1015-25.
-
Berlinski A. Effect of mask dead space and occlusion of mask holes on delivery of nebulized albuterol. Respir Care. 2014 Aug; 59(8):1228-32.
-
Maddox RP, Seupaul RA. Is ketamine effective for the management of acute asthma exacerbations in children? Ann Emerg Med. 2014 Mar; 63(3):309-10.
-
Awad S, Williams DK, Berlinski A. Longitudinal evaluation of compressor/nebulizer performance. Respir Care. 2014 Jul; 59(7):1053-61.
-
Berlinski A. In vitro evaluation of positive expiratory pressure devices attached to nebulizers. Respir Care. 2014 Feb; 59(2):216-22.
-
Berlinski A, Willis JR. Albuterol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator in vitro model. Respir Care. 2013 Jul; 58(7):1124-33.
-
Berlinski A. Nebulized albuterol delivery in a model of spontaneously breathing children with tracheostomy. Respir Care. 2013 Dec; 58(12):2076-86.
-
Dalabih AR, Bondi SA, Harris ZL, Saville BR, Wang W, Arnold DH. Aminophylline infusion for status asthmaticus in the pediatric critical care unit setting is independently associated with increased length of stay and time for symptom improvement. Pulm Pharmacol Ther. 2014 Feb; 27(1):57-61.
-
Berlinski A, Chavez A. Albuterol delivery via metered dose inhaler in a spontaneously breathing pediatric tracheostomy model. Pediatr Pulmonol. 2013 Oct; 48(10):1026-34.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|